Investigating the link between MCP-1 A-2518G, RANTES G-403A, CX3CR1 V249I and MTHFR C677T gene polymorphisms and the risk of acute myocardial infarction among Egyptians

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorHashad I.M.
dc.contributor.authorAbdel Rahman M.F.
dc.contributor.authorAlenina N.
dc.contributor.authorBader M.
dc.contributor.authorGad M.Z.
dc.contributor.otherClinical Biochemistry Unit
dc.contributor.otherFaculty of Pharmacy and Biotechnology
dc.contributor.otherGerman University in Cairo (GUC)
dc.contributor.otherNew Cairo City
dc.contributor.otherEgypt; Biochemistry Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherOctober University for Modern Science and Arts (MSA)
dc.contributor.other6th of October City
dc.contributor.otherEgypt; Cardiovascular Department
dc.contributor.otherMax-Delbr�ck-Center for Molecular Medicine
dc.contributor.otherBerlin-Buch
dc.contributor.otherGermany
dc.date.accessioned2020-01-09T20:41:23Z
dc.date.available2020-01-09T20:41:23Z
dc.date.issued2017
dc.descriptionScopus
dc.description.abstractBackground Acute myocardial infarction (AMI) is one of the leading causes of death among Egyptians. Monocyte chemoattractant protein-1 (MCP-1), regulation on activation normal T cell expressed and secreted (RANTES) and fractalkine (FKN) are chemokines that act as components of inflammatory response while methylenetetrahydrofolate reductase (MTHFR) is important enzyme in folate metabolism essential for homocysteine metabolism. Hyperhomocysteinemia has been linked to AMI. MCP-1 A-2518G, RANTES G-403A, CX3CR1 V249I and MTHFR C677T are important polymorphisms identified in MCP-1, RANTES, CX3CR1 and MTHFR genes respectively. There are conflicting data in the literature about their association with AMI. Therefore, the aim of the current study was to investigate the contribution of these gene variants to risk of AMI among Egyptians. Subjects and methods The study comprised 200 subjects; 100 AMI patients and 100 age-matched healthy controls. The MCP-1, RANTES, CX3CR1 and MTHFR genotypes were determined by restriction fragment length polymorphism (PCR-RFLP). Results Genotypes distributions for RANTES, fractalkine and MTHFR genes were significantly different between AMI patients and controls (p�=�0.0221, 0.0498 and 0.0083) while those results in MCP-1 were not significantly different. A significant risk for AMI with concurrent presence of RANTES (AG/AA), fractalkine (VV) and MTHFR (CT/TT) genotypes was observed. Conclusions 1 - Each of MTHFR 677T, RANTES-403A and CX3CR1 249V alleles is considered an independent risk factor for AMI. 2 - Concurrent presence of high risk genotypes of RANTES (AG/AA), fractalkine (VV) and MTHFR (CT/TT) increases risk of AMI more than their individual risks. 3 - MCP-1 polymorphism is not associated with AMI among Egyptians. � 2016 Elsevier B.V.en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=21100283722&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.1016/j.mgene.2016.10.010
dc.identifier.doiPubMed ID :
dc.identifier.issn22145400
dc.identifier.otherhttps://doi.org/10.1016/j.mgene.2016.10.010
dc.identifier.otherPubMed ID :
dc.identifier.urihttps://t.ly/epW9b
dc.language.isoEnglishen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofseriesMeta Gene
dc.relation.ispartofseries11
dc.subjectAcute myocardial infarctionen_US
dc.subjectChemokinesen_US
dc.subjectEgyptiansen_US
dc.subjectFractalkineen_US
dc.subjectMethylenetetrahydrofolate reductaseen_US
dc.subjectMonocyte chemoattractant protein-1en_US
dc.subjectRANTESen_US
dc.subjectSNPen_US
dc.subject5,10 methylenetetrahydrofolate reductase (FADH2)en_US
dc.subjectchemokine receptor CX3CR1en_US
dc.subjectgenomic DNAen_US
dc.subjectmonocyte chemotactic protein 1en_US
dc.subjectRANTESen_US
dc.subjecttriacylglycerolen_US
dc.subjectacute heart infarctionen_US
dc.subjectadulten_US
dc.subjectagar gel electrophoresisen_US
dc.subjectArticleen_US
dc.subjectblood samplingen_US
dc.subjectcholesterol blood levelen_US
dc.subjectcontrolled studyen_US
dc.subjectEgyptianen_US
dc.subjectfemaleen_US
dc.subjectgene frequencyen_US
dc.subjectgenetic risken_US
dc.subjectgenetic variabilityen_US
dc.subjectgenotypeen_US
dc.subjecthumanen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectpolymerase chain reactionen_US
dc.subjectpriority journalen_US
dc.subjectrestriction fragment length polymorphismen_US
dc.subjectsingle nucleotide polymorphismen_US
dc.titleInvestigating the link between MCP-1 A-2518G, RANTES G-403A, CX3CR1 V249I and MTHFR C677T gene polymorphisms and the risk of acute myocardial infarction among Egyptiansen_US
dc.typeArticleen_US
dcterms.isReferencedByAbdel Rahman, M.F., Hashad, I.M., Abou-Aisha, K., Abdel-Maksoud, S.M., Gad, M.Z., Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction (2015) Arch. Med. Sci., 11 (3), pp. 513-520; Almawi, W.Y., Ameen, G., Tamim, H., Finan, R.R., Irani-Hakime, N., Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease (2004) J. Thromb. Thrombolysis, 17 (3), pp. 199-205; Al-Qahtani, A., Alarifi, S., Al-Okail, M., Hussain, Z., Abdo, A., Sanai, F., Al-Anazi, M., Almajhdi, F.N., RANTES gene polymorphisms (?�403G�>�A and ?�28C�>�G) associated with hepatitis B virus infection in a Saudi population (2012) Genet. Mol. Res., 11 (2), pp. 855-862; Anderson, J.L., Muhlestein, J.B., Horne, B.D., Carlquist, J.F., Bair, T.L., Madsen, T.E., Pearson, R.R., Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease (2000) Circulation, 102 (11), pp. 1227-1232; Apostolakis, S., Baritaki, S., Kochiadakis, G.E., Igoumenidis, N.E., Panutsopulos, D., Spandidos, D.A., Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease (2007) Thromb. Res., 119 (1), pp. 63-71; Apostolakis, S., Amanatidou, V., Papadakis, E.G., Spandidos, D.A., Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis (2009) Atherosclerosis, 207 (1), pp. 8-15; Appay, V., Rowland-Jones, S.L., RANTES: a versatile and controversial chemokine (2001) Trends Immunol., 22 (2), pp. 83-87; Bazan, J.F., Bacon, K.B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D.R., Schall, T.J., A new class of membrane-bound chemokine with a CX3C motif (1997) Nature, 385 (6617), pp. 640-644; Boateng, S., Sanborn, T., Acute myocardial infarction (2013) Dis. Mon., 59 (3), pp. 83-96; Boger, C.A., Fischereder, M., Deinzer, M., Aslanidis, C., Schmitz, G., Stubanus, M., Banas, B., Kramer, B.K., RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients (2005) Atherosclerosis, 183 (1), pp. 121-129; Brilakis, E.S., Berger, P.B., Ballman, K.V., Rozen, R., Methylenetetrahydrofolate reductase (MTHFR) 677C�>�T and methionine synthase reductase (MTRR) 66A�>�G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid (2003) Atherosclerosis, 168 (2), pp. 315-322; Brugada, R., Marian, A.J., A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction (1997) Atherosclerosis, 128 (1), pp. 107-112; Cam, S.F., Sekuri, C., Sagcan, A., Ercan, E., Tengiz, I., Alioglu, E., Berdeli, A., Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease (2008) Scand. J. Clin. Lab. Invest., 68 (8), pp. 801-805; Cermakova, Z., Petrkova, J., Arakelyan, A., Drabek, J., Mrazek, F., Lukl, J., Petrek, M., The MCP-1-2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population (2005) Int. J. Immunogenet., 32 (5), pp. 315-318; Cui, K., Ge, X.Y., Ma, H.L., Association of the G403A polymorphism in the RANTES gene with coronary artery disease: a meta-analysis (2013) Genet. Mol. Res., 12 (3), pp. 3912-3918; Deeparani, T., Radhakrishna Pillai, M., Elavazhagan, T., Detection of MTHFR C677T and A1298C gene polymorphism in congenital heart disease (2009) Middle-East J. Sci. Res., 4 (2), pp. 127-132; Donato, A.J., Lesniewski, L.A., Delp, M.D., The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles (2005) Cardiovasc. Res., 66 (2), pp. 393-401; Donato, A.J., Gano, L.B., Eskurza, I., Silver, A.E., Gates, P.E., Jablonski, K., Seals, D.R., Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase (2009) Am. J. Physiol. Heart Circ. Physiol., 297 (1), pp. H425-H432; El Mahgoub, I.R., Afify, R.A., Aal, A.A., Beda, D.G., Association between the monocyte chemoattractant protein-1-2518G/A gene polymorphism and acute myocardial infarction patients among Egyptian population (2011) Blood Coagul. Fibrinolysis, 22 (1), pp. 7-13; Fahle, G.A., Fischer, S.H., Comparison of six commercial DNA extraction kits for recovery of cytomegalovirus DNA from spiked human specimens (2000) J. Clin. Microbiol., 38 (10), pp. 3860-3863; Fong, A.M., Robinson, L.A., Steeber, D.A., Tedder, T.F., Yoshie, O., Imai, T., Patel, D.D., Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow (1998) J. Exp. Med., 188 (8), pp. 1413-1419; Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J., van den Heuvel, L.P., A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase (1995) Nat. Genet., 10 (1), pp. 111-113; Gad, M.Z., Abdel Rahman, M.F., Hashad, I.M., Abdel-Maksoud, S.M., Farag, N.M., Abou-Aisha, K., Endothelial nitric oxide synthase (G894T) gene polymorphism in a random sample of the Egyptian population: comparison with myocardial infarction patients (2012) Genet. Test. Mol. Biomarkers, 16 (7), pp. 695-700; Goyette, P., Frosst, P., Rosenblatt, D.S., Rozen, R., Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency (1995) Am. J. Hum. Genet., 56 (5), pp. 1052-1059; Greenspoon, S.A., Scarpetta, M.A., Drayton, M.L., Turek, S.A., QIAamp spin columns as a method of DNA isolation for forensic casework (1998) J. Forensic Sci., 43 (5), pp. 1024-1030; Gugl, A., Renner, W., Seinost, G., Brodmann, M., Pabst, E., Wascher, T.C., Paulweber, B., Pilger, E., Two polymorphisms in the fracalkine receptor CX3CR1 are not associated with peripheral arterial disease (2003) Atherosclerosis, 166 (2), pp. 339-343; Hashad, I.M., Abdel Rahman, M.F., Abdel-Maksoud, S.M., Amr, K.S., Effat, L.K., Shaban, G.M., Gad, M.Z., C242T polymorphism of NADPH oxidase p22phox gene reduces the risk of coronary artery disease in a random sample of Egyptian population (2014) Mol. Biol. Rep., 41 (4), pp. 2281-2286; Huang, R.F., Huang, S.M., Lin, B.S., Wei, J.S., Liu, T.Z., Homocysteine thiolactone induces apoptotic DNA damage mediated by increased intracellular hydrogen peroxide and caspase 3 activation in HL-60 cells (2001) Life Sci., 68 (25), pp. 2799-2811; Jacques, P.F., Bostom, A.G., Williams, R.R., Ellison, R.C., Eckfeldt, J.H., Rosenberg, I.H., Selhub, J., Rozen, R., Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations (1996) Circulation, 93 (1), pp. 7-9; Jemaa, R., Rojbani, H., Kallel, A., Ben Ali, S., Feki, M., Chabrak, S., Elasmi, M., Kaabachi, N., Association between the ?�2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients (2008) Clin. Chim. Acta, 390 (1-2), pp. 122-125; Kang, S.S., Zhou, J., Wong, P.W., Kowalisyn, J., Strokosch, G., Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase (1988) Am. J. Hum. Genet., 43 (4), pp. 414-421; Kang, S.S., Wong, P.W., Susmano, A., Sora, J., Norusis, M., Ruggie, N., Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease (1991) Am. J. Hum. Genet., 48 (3), pp. 536-545; Kang, S.S., Passen, E.L., Ruggie, N., Wong, P.W., Sora, H., Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease (1993) Circulation, 88 (4), pp. 1463-1469; Kimouli, M., Miyakis, S., Georgakopoulos, P., Neofytou, E., Achimastos, A.D., Spandidos, D.A., Polymorphisms of fractalkine receptor CX3CR1 gene in patients with symptomatic and asymptomatic carotid artery stenosis (2009) J. Atheroscler. Thromb., 16 (5), pp. 604-610; Kiyici, S., Erturk, E., Budak, F., Ersoy, C., Tuncel, E., Duran, C., Oral, B., Imamoglu, S., Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy (2006) Arch. Med. Res., 37 (8), pp. 998-1003; Kumar, A.G., Ballantyne, C.M., Michael, L.H., Kukielka, G.L., Youker, K.A., Lindsey, M.L., Hawkins, H.K., Entman, M.L., Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium (1997) Circulation, 95 (3), pp. 693-700; Kwon, K.H., Lee, Y.C., Chung, J.H., Eun, Y.G., Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer (2013) J. Investig. Surg., 26 (6), pp. 319-324; Liang, R., Zhou, Y., Xie, J., Lv, W., Kang, B., Liang, Y., Chen, Y., Li, Y., Association of C677T gene polymorphisms of methylenetetrahydrofolate reductase and plasma homocysteine level with hyperlipidemia (2014) Nan Fang Yi Ke Da Xue Xue Bao, 34 (8), pp. 1195-1198; Liu, H., Chao, D., Nakayama, E.E., Taguchi, H., Goto, M., Xin, X., Takamatsu, J.K., Shioda, T., Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression (1999) Proc. Natl. Acad. Sci. U. S. A., 96 (8), pp. 4581-4585; Liu, J., Jia, Y.J., Li, X.L., Xu, R.X., Zhu, C.G., Guo, Y.L., Wu, N.Q., Li, J.J., RANTES gene G-403A polymorphism and coronary artery disease: a meta analysis of observational studies (2012) PLoS One, 7 (10), p. e47211; Ma, J., Stampfer, M.J., Hennekens, C.H., Frosst, P., Selhub, J., Horsford, J., Malinow, M.R., Rozen, R., Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians (1996) Circulation, 94 (10), pp. 2410-2416; Mager, A., Battler, A., Birnbaum, Y., Magal, N., Shohat, M., Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia (2002) Am. J. Cardiol., 89 (8), pp. 919-923; Malinow, M.R., Stampfer, M.J., Role of plasma homocyst(e)ine in arterial occlusive diseases (1994) Clin. Chem., 40 (6), pp. 857-858; Marsillach, J., Bertran, N., Camps, J., Ferre, N., Riu, F., Tous, M., Coll, B., Joven, J., The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease (2005) Clin. Biochem., 38 (12), pp. 1138-1140; McDermott, D.H., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Merrell, M.N., Epstein, N., Quyyumi, A.A., Murphy, P.M., Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis (2001) Circ. Res., 89 (5), pp. 401-407; McDermott, D.H., Yang, Q., Kathiresan, S., Cupples, L.A., Massaro, J.M., Keaney, J.F., Jr., Larson, M.G., Benjamin, E.J., CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study (2005) Circulation, 112 (8), pp. 1113-1120; Moatti, D., Faure, S., Fumeron, F., Amara Mel, W., Seknadji, P., McDermott, D.H., Debre, P., Combadiere, C., Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease (2001) Blood, 97 (7), pp. 1925-1928; Morawietz, H., Duerrschmidt, N., Niemann, B., Galle, J., Sawamura, T., Holtz, J., Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells (2001) Biochem. Biophys. Res. Commun., 284 (4), pp. 961-965; Nahas, R., Fakhoury, H.M., Chmaisse, H.N., Makki, R.F., Study of the association between ?�403G/A and ?�28C/G RANTES gene polymorphisms and asthma in Lebanon (2012) Ann. Thorac. Med., 7 (1), pp. 16-20; Nickel, R.G., Casolaro, V., Wahn, U., Beyer, K., Barnes, K.C., Plunkett, B.S., Freidhoff, L.R., Huang, S.K., Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES (2000) J. Immunol., 164 (3), pp. 1612-1616; Nygard, O., Nordrehaug, J.E., Refsum, H., Ueland, P.M., Farstad, M., Vollset, S.E., Plasma homocysteine levels and mortality in patients with coronary artery disease (1997) N. Engl. J. Med., 337 (4), pp. 230-236; O'Hayre, M., Salanga, C.L., Handel, T.M., Allen, S.J., Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment (2008) Biochem. J., 409 (3), pp. 635-649; Pucci, S., Mazzarelli, P., Zonetti, M.J., Fisco, T., Bonanno, E., Spagnoli, L.G., Mauriello, A., CX3CR1 receptor polymorphisms, Th1 cell recruitment, and acute myocardial infarction outcome: looking for a link (2013) Biomed. Res. Int., 2013, p. 451349; Rahman, M.F., Hashad, I.M., Abou-Aisha, K., Abdel-Maksoud, S.M., Gad, M.Z., Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction (2015) Arch. Med. Sci., 11 (3), pp. 513-520; Ramasawmy, R., Cunha-Neto, E., Fae, K.C., Martello, F.G., Muller, N.G., Cavalcanti, V.L., Ianni, B., Goldberg, A.C., The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease (2006) Clin. Infect. Dis., 43 (3), pp. 305-311; Rovin, B.H., Lu, L., Saxena, R., A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression (1999) Biochem. Biophys. Res. Commun., 259 (2), pp. 344-348; Simeoni, E., Winkelmann, B.R., Hoffmann, M.M., Fleury, S., Ruiz, J., Kappenberger, L., Marz, W., Vassalli, G., Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis (2004) Eur. Heart J., 25 (16), pp. 1438-1446; Singh, N., Rai, H., Sinha, N., Kumar, S., Pandey, C.M., Agrawal, S., Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians (2012) Genet Test Mol Biomarkers, 16 (7), pp. 756-760; Stamler, J.S., Slivka, A., Biological chemistry of thiols in the vasculature and in vascular-related disease (1996) Nutr. Rev., 54 (1), pp. 1-30; Stampfer, M.J., Malinow, M.R., Willett, W.C., Newcomer, L.M., Upson, B., Ullmann, D., Tishler, P.V., Hennekens, C.H., A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians (1992) JAMA, 268 (7), pp. 877-881; Szalai, C., Duba, J., Prohaszka, Z., Kalina, A., Szabo, T., Nagy, B., Horvath, L., Csaszar, A., Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518G/G genotype in CAD patients (2001) Atherosclerosis, 158 (1), pp. 233-239; Tavakkoly-Bazzaz, J., Amiri, P., Tajmir-Riahi, M., Javidi, D., Khojasteh-Fard, M., Taheri, Z., Tabrizi, A., Amoli, M.M., RANTES gene mRNA expression and its ?�403 G/A promoter polymorphism in coronary artery disease (2011) Gene, 487 (1), pp. 103-106; van Bockxmeer, F.M., Mamotte, C.D., Vasikaran, S.D., Taylor, R.R., Methylenetetrahydrofolate reductase gene and coronary artery disease (1997) Circulation, 95 (1), pp. 21-23; Wilcken, D.E., Wang, X.L., Wilcken, B., Methylenetetrahydrofolate reductase (MTHFR) mutation, homocyst(e)ine, and coronary artery disease (1997) Circulation, 96 (8), pp. 2738-2740; Zhang, X., Han, Y., Kang, J., Yan, C., A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population (2009) Clin. Chim. Acta, 403 (1-2), pp. 241-243
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
avatar_scholar_128.png
Size:
2.73 KB
Format:
Portable Network Graphics
Description: